Bluejay Diagnostics (BJDX) Non-Current Assets (2020 - 2026)

Bluejay Diagnostics has disclosed Non-Current Assets across 7 years of filings, most recently posting $1.6 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $1.6 million, down 4.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.5 million (down 8.63% YoY), and the FY2025 annual result was $1.7 million, down 5.85% from the prior year.
• Non-Current Assets came in at $1.6 million for Q1 2026 at Bluejay Diagnostics, down from $1.7 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $2.0 million in Q1 2023 to a low of $760675.0 in Q1 2022.
• The 5-year median for Non-Current Assets is $1.7 million (2025), against an average of $1.6 million.
• Across the five-year window, Non-Current Assets surged 393.1% in 2022 and fell 18.18% in 2024, its largest moves.
• Bluejay Diagnostics' Non-Current Assets stood at $1.7 million in 2022, then declined by 4.91% to $1.6 million in 2023, then grew by 6.73% to $1.8 million in 2024, then dropped by 5.85% to $1.7 million in 2025, then declined by 1.48% to $1.6 million in 2026.
• The last three Non-Current Assets figures came in at $1.6 million (Q1 2026), $1.7 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.